// startup autopsy
CS-Keys
A biotech that couldn't survive the market crash
marketfitSlow Death
Years-long decline before final shutdown · Fatal mistake: CS-Keys failed to reach any clinical milestone before its funding ran out during the post-2008 biotech investment freeze.
Key Events Timeline
FOUNDING
CS-Keys founded as a biotech startup focused on early-stage research and development.
FUNDING
CS-Keys secures its final known funding round totaling $6.535M to advance its research pipeline.
PIVOT
Post-2008 crash forces CS-Keys to attempt pivot in research focus as investor appetite for small biotech collapses.
SHUTDOWN
CS-Keys ceases operations after failing to secure additional funding or achieve clinical validation milestones.